O
Ovensa Inc.
0 followers
Ovensa provides nanomedicine technology platforms, which deliver targeted oral therapy with mucosal and brain-barrier crossing properties. Ovensa focuses on developing personalized treatments for cancer and neurodegenerative diseases and on preventing antibiotic resistance.
Org chart
Stéphane Gagné
Founder, President & CEO
Collapse
No reports!
Board & advisors
Steven Splinter
Director
Quynh-Thu Le
Scientific Advisor
Mark D. Vincent
Scientific Advisor
Steven De Vleeschouwer
Scientific Advisor
Jonathan Gagnon
Scientific Advisor
Nicolas Bertrand
Scientific Advisor